Catalyst calendar

Biotech catalysts in January 2027

4 catalysts are dated to January 2027, including 2 FDA decisions. The first with a set day is the FDA decision on ANKTIVA (supplemental application) (ImmunityBio) on Jan 6. Events placed only in a quarter or half-year are on the 90-day calendar.

Firm dates · a specific day set by the company or regulator

Next 90 days

Jan 6
in 85 days
ANKTIVA · FDA decision (supplemental application) · NMIBC · BCG-unresponsive, papillary disease without CIS
ImmunityBio (IBRX)·Source

Later

Jan 29
in 108 days
Ulixacaltamide · FDA decision · Essential tremor
Praxis Precision Medicines (PRAX)·Source

Estimated timing · a month, quarter, half-year or year-end the company gave

Expected in January 2027

January 2027
Libervant Full Approval for 12+ Age Group
Aquestive Therapeutics (AQST)·Source
early January 2027
AX-0811 · CTA submission · Cholestatic disease · NTCP modulation
ProQR Therapeutics (PRQR)·Source